Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Dis Esophagus ; 21(7): 607-11, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18430178

RESUMEN

Perioperative chemotherapy (CT) and chemoradiotherapy are widely used for advanced esophageal cancer. We evaluated the chemosensitivity of patients displaying recurrent esophageal cancer after esophagectomy with perioperative CT. From the database at National Cancer Center Hospital in Tokyo, we extracted recurrent esophageal cancer cases after perioperative CT and evaluated the effectiveness of the first CT against the recurrent disease according to the duration between termination of the original perioperative CT and recurrence with treatment-free intervals (TFIs) 6 months. Systemic CT for their recurrent disease was performed for 30 esophageal cancer patients after perioperative CT. All patients received 5-fluorouracil and cisplatin as perioperative CT, with relapses occurring at TFIs 6 months in 19 patients (all received platinum-containing regimens). The response rate of patients experiencing a recurrence at TFIs 6 months was 0 and 37% (P = 0.029), the median progression-free survival was 2.8 and 4.8 months (log-rank P = 0.001) and the median overall survival was 6.1 and 10.2 months (log-rank P = 0.012), respectively. Recurrence at the TFI

Asunto(s)
Antineoplásicos/uso terapéutico , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/secundario , Neoplasias Esofágicas/tratamiento farmacológico , Neoplasias Esofágicas/cirugía , Anciano , Carcinoma de Células Escamosas/cirugía , Quimioterapia Adyuvante , Cisplatino/uso terapéutico , Estudios de Cohortes , Bases de Datos Factuales , Supervivencia sin Enfermedad , Neoplasias Esofágicas/patología , Esofagectomía , Femenino , Fluorouracilo/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
2.
Phytomedicine ; 12(8): 549-54, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16121514

RESUMEN

OBJECTIVE: To evaluate the effects of Hochuekkito, a traditional Japanese and Chinese medicine, in the treatment of elderly patients with general weakness. To devise a suitable study design for assessing the clinical effectiveness of traditional herbal medicines. METHODS: Fifteen elderly patients (mean +/- SD: age 78.4 +/- 7.8; m/f 3/12) participated in this study. A multicenter, prospective, randomized, double-blind, placebo-controlled study with N of one and responder restricted design was performed. After the run-in period, the patients were divided into responders and non-responders. Only responders were entered in the study, and were randomized into three groups: an active-placebo group, a placebo-active group and an active-active group. The study consisted of two 6-week terms with a 2-week washout period in between. We assessed the Short Form 36 Health Survey (SF-36) and Profile of Mood States (POMS) as an endpoint of quality of life (QOL). In addition, we assessed the biodefense status by measuring the natural killer cytolytic activity (NK activity), IL-2 producing activity of peripheral lymphocytes, lymphocyte proliferating activity and lymphocyte cell-surface antigens. RESULTS: The physical component summary of the SF-36 analysis significantly improved in the Hochuekkito-treated group. Four components (A-H: anger-hostility, F: fatigue, T-A: tension-anxiety, C: confusion) out of six improved in the Hochuekkito-treated group in the POMS analysis. Lymphocyte proliferating activity improved in the Hochuekkito-treated group but not significantly. Concerning the surface antigens of peripheral lymphocytes, the population of CD3 positive cells and CD3CD4 double positive cells increased in the Hochuekkito-treated group. CONCLUSION: We revealed that Hochuekkito improved the QOL and immunological status of elderly patients with weakness by randomized controlled trial. Our study design might be useful for assessing the efficacy of traditional herbal medicine in the future.


Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Plantas Medicinales , Afecto , Anciano , Antidepresivos/administración & dosificación , Antidepresivos/farmacología , Trastorno Depresivo/patología , Método Doble Ciego , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/uso terapéutico , Femenino , Humanos , Japón , Masculino , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Estudios Prospectivos , Calidad de Vida , Encuestas y Cuestionarios , Linfocitos T/efectos de los fármacos , Resultado del Tratamiento
3.
Phytomedicine ; 12(5): 327-32, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15957365

RESUMEN

Juzen-taiho-to (TJ-48), a mixture of extracts from 10 medicinal herbs, has been used traditionally to treat patients with anemia, anorexia or fatigue. It is well known that the treatment of TJ-48 result in the decrease of patient's complaints, as well as the increase of NK cytolytic activity (NK activity) although its augmentation is not clear in the other kampo formula from the clinical viewpoint. To investigate its biological activities, such as the augmentation of NK activity, we analyzed the effects of TJ-48 on the expression of killer-cell immunoglobulin-like receptors (KIRs) in vitro experiment. The peripheral lymphocytes were incubated in medium alone, or medium containing TJ-48 or interleukin-2 (IL-2) plus TJ-48 at several concentrations for 48 h. After each incubation, cells were collected and their KIRs were detected by flow cytometry using monoclonal antibodies CD158a and CD158b. TJ-48 increased the populations of CD16+CD158a+ and CD16+CD158b+ cells in a dose-dependent manner. In contrast, CD16-CD158a/b+ cells did not increase. Additionally, the extract of TJ-48 enhanced the increase of KIRs expression induced by IL-2. These actions contribute to the augmentation of NK cytolytic activity by TJ-48, and might explain, in part, its antitumor effects which has been observed in vivo.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Medicamentos Herbarios Chinos/farmacología , Células Asesinas Naturales/efectos de los fármacos , Fitoterapia , Extractos Vegetales/farmacología , Plantas Medicinales , Receptores Inmunológicos/metabolismo , Adyuvantes Inmunológicos/administración & dosificación , Adyuvantes Inmunológicos/uso terapéutico , Antígenos CD8/efectos de los fármacos , Antígenos CD8/metabolismo , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/uso terapéutico , Citometría de Flujo , Humanos , Interleucina-2/farmacología , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/metabolismo , Linfocitos/efectos de los fármacos , Linfocitos/inmunología , Linfocitos/metabolismo , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico
4.
Phytomedicine ; 12(5): 333-7, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15957366

RESUMEN

The vasodilative effect of perillaldehyde, one of the major oil components in Perilla frutescens BRITTON, was studied using isolated rat aorta. Perillaldehyde at final concentrations of 0.01 to 1 mM showed dose-dependent relaxation of the aorta contracted by treatment with prostaglandin F2alpha or norepinephrine. Neither the presence of NG-nitro-L-arginine methyl ester nor removal of the aortic endothelium affected the vasodilatation, suggesting that perillaldehyde exerts a direct effect on vascular smooth muscle cells. The vasodilative effect of perillaldehyde was not inhibited by pretreatment with a beta-adrenergic receptor blocker (propranolol), an inhibitor of phosphodiesterase (theophylline), a delayed rectifier K+ channel blocker (tetraethylammonium chloride), or an ATP-sensitive K+ channel blocker (glibenclamide). However, perillaldehyde showed contrasting effects on vasodilatation of the aorta contracted by an influx of extracellular Ca2+ - perillaldehyde caused little vasodilatation on the aorta contracted by the Ca2+ ionophore A23187, while it inhibited the vasoconstriction induced by treatment with high-concentration K+, which dominantly opened the voltage-dependent Ca2+ channel. These results suggest that the vasodilative effect of perillaldehyde is derived from blocking the Ca2+ channels.


Asunto(s)
Aorta Torácica/efectos de los fármacos , Monoterpenos/farmacología , Perilla frutescens , Fitoterapia , Vasodilatadores/farmacología , Animales , Canales de Calcio/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Masculino , Monoterpenos/administración & dosificación , Monoterpenos/uso terapéutico , Relajación Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Aceites de Plantas/administración & dosificación , Aceites de Plantas/farmacología , Aceites de Plantas/uso terapéutico , Ratas , Ratas Wistar , Vasodilatadores/administración & dosificación , Vasodilatadores/uso terapéutico
5.
Phytomedicine ; 11(5): 404-10, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15330495

RESUMEN

Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is a traditional Chinese/Japanese medical (Kampo) formulation that has been administered to patients with "Oketsu" (blood stagnation) syndrome. In the process of neuronal cell death induced by brain ischemia, excessive generation of nitric oxide (NO) free radicals is implicated in the neurotoxicity. In the present study, we examined the protective effects of KBG and its constituent medicinal plants against NO donors, sodium nitroprusside (SNP) and 2,2'-(hydroxynitrosohydrazino)bis-ethanamine (NOC18)-induced neuronal death in cultured rat cerebellar granule cells (CGCs). MTT assay showed cell viability to be significantly increased by the addition of KBG extract (KBGE) (100 microg/ml), Cinnamomi Cortex extract (CCE) (3, 10 and 30 microg/ml), Paeoniae Radix extract (PRE) (100 microg/ml) and Moutan Cortex extract (MCE) (10 and 30 microg/ml) compared with exposure to SNP (30 microM, 24 h) only. Also, cell viability was significantly increased by the addition of KBGE (100 and 300 microg/ml), CCE (30 and 100 microg/ml), PRE (100 and 300 microg/ml) and MCE (30 and 100 microg/ml) compared with exposure to NOC 18 (100 microM, 48 h) only. Persicae Semen extract and Hoelen extract did not protect against NO donor-induced neuronal death. These results suggest that KBG has protective effect against NO-mediated neuronal death in cultured CGCs and that it is derived from Cinnamomi Cortex, Paeoniae Radix and Moutan Cortex.


Asunto(s)
Cerebelo/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Fitoterapia , Plantas Medicinales , Sustancias Protectoras/farmacología , Animales , Isquemia Encefálica/inducido químicamente , Isquemia Encefálica/prevención & control , Supervivencia Celular/efectos de los fármacos , Cerebelo/citología , Cinnamomum , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/uso terapéutico , Nitroprusiato , Compuestos Nitrosos , Paeonia , Polyporales , Sustancias Protectoras/administración & dosificación , Sustancias Protectoras/uso terapéutico , Prunus , Ratas , Ratas Wistar
6.
Phytomedicine ; 11(2-3): 188-95, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15070171

RESUMEN

Keishi-bukuryo-gan (Gui-zhi-fu-ling-wan) is a formula used for the improvement of blood circulation. Recently it has often also been used for arteriosclerosis. One of the mechanisms involved is thought to be the improvement of endothelial dysfunction, but the details are still unclear. In this study, the effect of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats was studied. Rats were given Keishi-bukuryo-gan in chow for 30 weeks. Body weight, blood glucose, endothelium-dependent/-independent relaxation, vasocontraction by free radical-induced and contractive prostanoids, triglyceride, advanced glycation endproduct, lipid peroxides, serum NO2-/NO3- and blood viscosity were measured. The results indicated that Keishi-bukuryo-gan caused a decrease in endothelium-dependent relaxation by acetylcholine to become significantly increased, and vasocontraction induced by free radicals and contractive prostanoids was significantly decreased. Furthermore, serum NO2-/NO3- and blood viscosity were significantly decreased. From these results, it was supposed that Keishi-bukuryo-gan exerted a protective effect on the endothelium. The WBN/kob rat is a useful study model for the complications of human diabetes, and Keishi-bukuryo-gan showed a protective effect against vascular injury in the susceptible rat.


Asunto(s)
Medicamentos Herbarios Chinos , Medicamentos Herbarios Chinos/farmacología , Fitoterapia , Vasodilatadores/farmacología , Administración Oral , Alimentación Animal , Animales , Arteriosclerosis/prevención & control , Glucemia/efectos de los fármacos , Viscosidad Sanguínea/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/uso terapéutico , Masculino , Nitratos/sangre , Prostaglandinas , Distribución Aleatoria , Ratas , Ratas Endogámicas , Ratas Wistar , Triglicéridos/metabolismo , Vasodilatación/efectos de los fármacos , Vasodilatadores/administración & dosificación , Vasodilatadores/uso terapéutico
7.
Phytomedicine ; 11(1): 5-10, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14971716

RESUMEN

We found that a herbal medicine (Mao-to) relieves the side effects of interferon (IFN)-beta and the combination therapy improves the biochemical response rate. However, the exact mechanism by which Mao-to is effective remains to be established. We conducted a controlled trial to clarify the effects of Mao-to. The study was carried out in 18 patients with chronic hepatitis C, and we examined subjective symptoms, body temperature and cytokines such as interleukin (IL)-beta, IL-1receptor antagonist (ra), IL-6 and TNF-alpha. Each patient received 6 million units of IFN-beta intravenously. Mao-to was given orally just before, just after, and 1 hour after IFN administration. The control study was carried out 6 months after the combination therapy of Mao-to and IFN-beta. The scores for general malaise, arthralgia and discomfort were significantly lower in the combination group than in control group. Body temperature did not significantly differ between the two groups. Plasma IL-6 level and IL-1ra were significantly elevated in the combination group compared to control (P = 0.0057 and 0.0003, respectively). Mao-to did not affect plasma concentrations of IL-1beta and TNF-alpha. We considered the increment of IL-1ra caused by Mao-to is to be one of the key factors involved in reducing the flu-like symptoms accompanying IFN-beta and improving the biochemical response rate.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Hepatitis C Crónica/tratamiento farmacológico , Factores Inmunológicos/uso terapéutico , Interferón beta/uso terapéutico , Fitoterapia , Plantas Medicinales , Adulto , Anciano , Temperatura Corporal , Citocinas/sangre , Quimioterapia Combinada , Medicamentos Herbarios Chinos/administración & dosificación , Femenino , Hepatitis C Crónica/inmunología , Humanos , Factores Inmunológicos/administración & dosificación , Infusiones Intravenosas , Interferón beta/administración & dosificación , Proteína Antagonista del Receptor de Interleucina 1 , Interleucina-1/sangre , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Sialoglicoproteínas/sangre , Factor de Necrosis Tumoral alfa/metabolismo
8.
Phytomedicine ; 10(6-7): 459-66, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-13678228

RESUMEN

Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is one of the prescriptions in Japanese traditional medicine for improving the "oketsu" syndrome, so-called blood stasis syndrome. "Oketsu" syndrome is an important pathological conception in Japanese traditional medicine and often accompanies cerebro-vascular disorders. Previously, we were able to reveal a deterioration of RBC (Red blood cell) deformability and viscoelasticity in patients with "oketsu" syndrome. The purpose of the present study was to evaluate whether KBG has an effect on RBC deformability in comparison with pentoxifylline (PXF). The subjects were 30 male patients with multiple lacunar infarctions. Eighteen patients (44-79 yrs, mean +/- SD, 66.1 +/- 10.7 yrs) were treated with 12 g of KBG daily for 4 weeks (KBG group). Twelve patients (59-78 yrs, 70.7 +/- 6.4 yrs) were treated with 300 mg of PXF daily for 4 weeks (PXF group). Based on the "oketsu" score, the patients of each group were divided into two subgroups, a non-"oketsu" group ("oketsu" score 20 points or less) and an "oketsu" group ("oketsu" score 21 points or higher). KBG had significant effects on RBC deformability as evaluated by filtration method. KBG also significantly increased intracellular ATP content, as did PXF. Moreover, KBG was more effective for patients with a more severe "oketsu" state. However, PXF was effective only in patients with "oketsu" syndrome, who might have deteriorated RBC deformability. In conclusion, the effect of KBG on RBC deformability was by no means inferior to PXF.


Asunto(s)
Infarto Cerebral/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Deformación Eritrocítica/efectos de los fármacos , Pentoxifilina/uso terapéutico , Fitoterapia , Inhibidores de Agregación Plaquetaria/uso terapéutico , Administración Oral , Adulto , Anciano , Infarto Cerebral/patología , Cromatografía Líquida de Alta Presión , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/farmacología , Hemólisis/efectos de los fármacos , Humanos , Japón , Masculino , Medicina Tradicional , Persona de Mediana Edad , Pentoxifilina/administración & dosificación , Pentoxifilina/farmacología , Inhibidores de Agregación Plaquetaria/administración & dosificación , Inhibidores de Agregación Plaquetaria/farmacología , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
9.
Phytomedicine ; 10(2-3): 122-6, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12725564

RESUMEN

Using a high-performance liquid chromatographic method and mass spectrometry analysis, we successfully measured the absorption of orally administered procyanidin B-2 and procyanidin B-3 isolated from Cinnamonomi cortex (the bark of Cinnamomum cassia Blume) in the rat plasma. This method used a TSK- GEL ODS-80TS column, two solvents (A: 0.01% acetic acid; B: methanol with 0.01% acetic acid) in a linear gradient at a flow-rate of 1.0 ml/min, and fluorescence detection at excitation and emission wavelengths of 220 and 327 nm.


Asunto(s)
Biflavonoides , Catequina/farmacología , Cinnamomum aromaticum , Proantocianidinas , Administración Oral , Animales , Catequina/sangre , Catequina/química , Cromatografía Líquida de Alta Presión , Masculino , Espectrometría de Masas , Extractos Vegetales/farmacología , Ratas , Ratas Wistar , Factores de Tiempo
10.
Clin Exp Rheumatol ; 21(1): 57-62, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12673890

RESUMEN

OBJECTIVE: Crude preparations of Fun-boi (Stephania tetrandra), a traditional antirheumatic herb, have been reported to have immunomodulatory effects on both cell-mediated and humoral immunity in vitro, but little is known about the mode of action in vivo. The objective of this study was therefore to evaluate the efficacy of Fun-boi against arthritis and its effect on the immune system. METHODS: Mice were divided into the following 3 groups of 7 mice each: 1) a normal group, not treated to cause collagen-induced arthritis (CIA), received water orally; 2) a control group with CIA received water orally; and 3) the Fun-boi group with CIA, received Fun-boi (3 mg/g body weight/day) orally. We analyzed the arthritis score, the serum anti-type II collagen (CII) antibody level, and the percentage of the following lymphocyte subsets from lymphoid organs: B220, CD3/CD4, CD3/CD8 and CD40L/CD4 lymphocytes from blood or lymph nodes; and CD4-CD8-, CD4+CD8+, CD4+CD8- and CD4-CD8+ from the thymus. RESULTS: Fun-boi therapy markedly reduced the severity of arthritis (p < 0.001) and tended to reduce the serum anti-CII antibody level (p = 0.06). Whereas CII immunization of DBA/1J mice caused a significant redistribution of CD3/CD8 lymphocytes from blood or lymph nodes, Fun-boi therapy caused significant normalization of the same types of lymphocyte subsets from lymph nodes, but did not affect the CD4 or CD4/CD40L lymphocyte subsets. CONCLUSION: These results demonstrate that Fun-boi therapy exerts therapeutic effects in CIA mice, possibly by causing immunomodulatory effects at specific sites.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Artritis Experimental/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Fitoterapia , Stephania tetrandra , Adyuvantes Inmunológicos/administración & dosificación , Administración Oral , Animales , Artritis Experimental/fisiopatología , Colágeno Tipo II/inmunología , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/administración & dosificación , Ganglios Linfáticos/efectos de los fármacos , Ganglios Linfáticos/patología , Subgrupos Linfocitarios/efectos de los fármacos , Subgrupos Linfocitarios/patología , Masculino , Ratones , Ratones Endogámicos DBA , Raíces de Plantas/química , Plantas Medicinales/química , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
11.
Phytomedicine ; 9(7): 636-40, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12487328

RESUMEN

The present study is designed to test our hypothesis that the ingestion of Uncaria sinensis (US), the main medicinal plant of Choto-san (Diao-teng-san, CS), would protect red blood cell (RBC) membrane from free radical-induced oxidation if polyphenolics in US could be absorbed and circulated in blood. When incubated with RBC suspension, Choto-san extract (CSE) and Uncaria sinensis extract (USE) exhibited strong protection for RBC membrane against hemolysis induced by 2,2-azo-bis (2-amidinopropane) dihydrochloride (AAPH), an azo free-radical initiator. The inhibitory effect was dose-dependent at concentrations of 50 to 1000 microg/mL. Ingestion of 200 mg of USE was associated with a significant decrease in susceptibility of RBC to hemolysis in rats. Furthermore, caffeic acid, an antioxidative hydroxycinnamic acid, was identified in rat plasma after administration of URE.


Asunto(s)
Medicamentos Herbarios Chinos , Eritrocitos/efectos de los fármacos , Hemólisis/efectos de los fármacos , Extractos Vegetales/farmacología , Tallos de la Planta/química , Uncaria , Amidinas/farmacología , Animales , Relación Dosis-Respuesta a Droga , Radicales Libres/efectos adversos , Masculino , Ratas , Ratas Wistar
12.
Phytomedicine ; 9(5): 373-6, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12222654

RESUMEN

With prolonged use of rhubarb-containing Kampo medicines, some patients come to ask for high-dose rhubarb because of deteriorated reactivity to rhubarb. We divided patients into two groups in terms of rhubarb-dose, and compared clinical backgrounds between regular-dose group and excess-dose group. Patients who were treated with rhubarb-containing Kampo extracts (manufactured prescriptions) or Kampo formulae (decoctions) for more than 12 months were enrolled. These two groups were compared for age, sex, shape of stool, abdominal symptoms, existence of hemorrhoids, Kampo diagnosis of abdomen, past stimulant laxative use, duration of stimulant laxative use before the first administration of rhubarb, duration of rhubarb use in our hospital, and initial existence of stimulant pain caused by taking stimulant laxatives for the first time. No significant difference was shown between the two groups in terms of age, duration of stimulant laxative-use before the first prescription of rhubarb, shape of stool, abdominal symptoms, existence of hemorrhoids, or duration of rhubarb-use. However, most patients in the regular-dose group had initial stimulant pain of the abdomen upon taking stimulant laxatives for the first time, but most patients in the excess-dose group did not (p < 0.001). All patients except one in the regular dose group had the sign of "umbilical region tenderness on pressure", but half of the excess-dose group did not have it (p = 0.041). Based on these findings, the absence of "initial stimulant pain" and the absence of "umbilical region tenderness on pressure" may predict increasing or excess use of rhubarb, and long-term use of rhubarb should be discouraged more strongly in the patients without these signs.


Asunto(s)
Catárticos/administración & dosificación , Medicina Kampo , Rheum , Catárticos/efectos adversos , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Masculino , Persona de Mediana Edad
13.
Phytomedicine ; 9(5): 455-60, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12222668

RESUMEN

Oren-gedoku-to (Huanglian-Jie-Du-Tang, OGT) has been used for the treatment of cerebrovascular disease, hypertension, gastritis and liver disease in Japan. The present study was to test whether ingestion of OGT extract (TJ-15) would affect the metabolism of fatty acids and the usual antioxidant molecule (such as albumin, uric acid and bilirubin) levels in human plasma. After the administration of TJ-15, plasma total cholesterol and the triglyceride level significantly decreased, and lipoprotein lipase mass increased. Significant enhancement of plasma albumin level and reduction of the total plasma protein level resulted in an increment of the albumin/globulin ratio. Plasma fibrinogen, an independent risk factor for cerebrovascular disease, declined considerably, but the reduction was not statistically significant. The findings of this study suggest that ingestion of TJ-15 improves the microcirculation through lipid and protein metabolisms, and is useful for the treatment of cerebral vascular attack in human.


Asunto(s)
Medicamentos Herbarios Chinos/administración & dosificación , Albúmina Sérica/metabolismo , Triglicéridos/sangre , Cromatografía Líquida de Alta Presión , Ensayo de Inmunoadsorción Enzimática , Humanos , Masculino
14.
Phytomedicine ; 9(4): 280-7, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-12120808

RESUMEN

We retrospectively examined the summaries of all admission records of patients from 1979 to 1999 in our department, and selected for further study all liver injuries suspected of being related to Kampo medicines. Among 2,496 summaries, 30 summaries described liver disorders suspected of being related to Kampo medicines. Whether there was a causal relationship between the use of Kampo medication and the occurrence of liver injury was assessed according to the criteria described by Haller and Benowitz (2000), independently of the results of the lymphocyte transformation test (LTT). Among 30 events, we concluded that 9 were definitely unrelated, and 6 were probably unrelated to the use of Kampo medicines. Nine events (0.36% of 2,496 patient admissions and 0.06% of 14,616 outpatients) were considered possibly related, and only 6 events (0.24% of 2,496 patient admissions and 0.04% of 14,616 outpatients) were judged to be definitely or probably related to Kampo medicines. Low-grade eosinophilia was observed in a few patients of these "related" groups, and no fever or rash was observed in these "related" groups. Other clinical features, including type of liver injury, duration of Kampo medicine-use, recovery period and laboratory data, were not different from liver injuries associated with western drugs. Most patients in the definitely "unrelated" group were positive in the LTT for the suspect Kampo medicine, suggesting that the LTT may be unreliable for the diagnosis of Kampo-medicine-induced liver injury. From 1979 to 1999, our use of Kampo medicines to treat patients resulted in a low rate of liver injury and no fatalities.


Asunto(s)
Enfermedad Hepática Crónica Inducida por Sustancias y Drogas/epidemiología , Enfermedad Hepática Crónica Inducida por Sustancias y Drogas/etiología , Medicamentos Herbarios Chinos/efectos adversos , Medicina Kampo , Fitoterapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Factores de Confusión Epidemiológicos , Femenino , Humanos , Incidencia , Japón/epidemiología , Activación de Linfocitos , Masculino , Persona de Mediana Edad , Admisión del Paciente/estadística & datos numéricos , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados , Estudios Retrospectivos
15.
Phytomedicine ; 9(3): 195-201, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12046858

RESUMEN

Two published case reports described palliation of disease after Seihai-to therapy for refractory aspiration pneumonia caused by recurrent laryngeal nerve paralysis and cerebrovascular disease. We undertook an open-label trial in patients with relapsing aspiration pneumonia. Fifteen patients with relapsing aspiration pneumonia were randomly divided into conventional therapy group (n = 8) or Seihai-to group (n = 7). In Seihai-to group, patients were treated with Seihai-to in addition to conventional therapy (Western medicines). Frequency of feverish days and antibiotics-use, CRP value and chest CT or X-ray findings were compared between the two groups during the study period of 16 weeks. In the Seihai-to group, the latency of swallowing reflex was measured in 6 patients before and after administration of Seihai-to. The mean values of fever index, CRP value and antibiotics-use in the Seihai-to group were decreased significantly, compared with those of the conventional therapy group. However, the latency of the swallowing reflex after 4 weeks of treatment was not significantly changed (p = 0.249), compared with the latency before administration of Seihai-to. No adverse reaction was observed in either group. Seihai-to was effective in reducing relapse of aspiration pneumonia in this small group. Seihai-to might not improve the swallowing reflex, but might instead improve a defense mechanism or excessive inflammation caused by pneumonia in the lower airway. Further evaluation of Seihai-to therapy for patients with aspiration pneumonia in a larger population is warranted.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Fitoterapia , Neumonía por Aspiración/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Deglución/fisiología , Medicamentos Herbarios Chinos/administración & dosificación , Femenino , Humanos , Pacientes Internos , Masculino , Medicina Kampo , Cuidados Paliativos , Proyectos Piloto , Neumonía por Aspiración/diagnóstico por imagen , Neumonía por Aspiración/patología , Estudios Prospectivos , Recurrencia , Reflejo/fisiología , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
16.
Phytomedicine ; 9(2): 93-8, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11995955

RESUMEN

Choto-san is a formula used for the treatment of headache and vertigo. Recently it has often also been used for hypertension and dementia. One of the mechanisms involved is thought to be the improvement of blood circulation, but the details are still unclear. In this study, the effect of Chotosan was studied on nitric oxide (NO) function, hemorheological factors and endothelial function in stroke-prone spontaneously hypertensive rats (SHR-SP). Rats were given Choto-san in drinking water for eight weeks. Body weight, blood pressure, serum NO2-/NO3-, lipid peroxides, blood viscosity, erythrocyte deformability and endothelium-dependent/-independent relaxation were measured. The results indicated that Choto-san caused a decrease in blood pressure and an increase in erythrocyte deformability and NO function. Blood viscosity was not changed. Furthermore, endothelium-dependent relaxation by acetylcholine was significantly increased as compared to control. In this study, it was supposed that Choto-san had a protective effect on the endothelium. SHR-SP is a useful model for human brain stroke, and Choto-san showed a protective effect against cerebral vascular injury in the susceptible rat.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Hipertensión/fisiopatología , Óxido Nítrico/fisiología , Accidente Cerebrovascular/sangre , Acetilcolina/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Viscosidad Sanguínea/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/uso terapéutico , Endotelio Vascular/efectos de los fármacos , Deformación Eritrocítica/efectos de los fármacos , Hemorreología/métodos , Hipertensión/tratamiento farmacológico , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Masculino , Nitratos/sangre , Nitritos/sangre , Nitroprusiato , Fitoterapia , Ratas , Ratas Endogámicas SHR , Accidente Cerebrovascular/tratamiento farmacológico , Vasodilatación/efectos de los fármacos , Vasodilatadores/farmacología
17.
Arch Phys Med Rehabil ; 82(11): 1596-603, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11689981

RESUMEN

OBJECTIVE: To evaluate the effects of electric stimulation in preventing acute muscle atrophy after spinal cord transection in rats. DESIGN: A randomized experimental design. SETTING: Animal facilities for experimental medicine. ANIMALS: Fifty-six adult male Wistar rats assigned to control, low-frequency, and high-frequency groups. INTERVENTIONS: The rats were implanted with a percutaneous intramuscular electrode in the vicinity of the peroneal nerve; then the spinal cord was transected in a T9 level. The stimulation frequency was low (20Hz) or high (100Hz). The stimulation cycle was 4 seconds of stimulation every 8 seconds. MAIN OUTCOME MEASUREMENTS: The lesser fiber diameters from type 1, 2A, and 2B muscle fibers were measured. In another assessment, maximal contraction force was measured. The muscle force produced at 20 and 100Hz was expressed as increasing values in tetanic force. RESULTS: Comparison between nonstimulated and stimulated tibialis anterior muscles found that atrophy of type 1 fibers (p < .01) and type 2B fibers (p < .05) at both stimulated levels and of type 2A fibers at 100-Hz level (p < .05) was prevented by therapeutic electric stimulation (TES). There were significant differences in the size of muscle fiber diameter between nonstimulated and stimulated muscles at 100Hz in type 2A and, markedly, in type 2B. The increasing value of muscle force was significantly greater at 100Hz than at 20Hz (p < .05). No significant histologic differences were observed between high- and low-frequency stimulated fibers of any of the 3 muscle types. CONCLUSIONS: Acute atrophy of muscle fibers was more effectively prevented by high-frequency stimulation (100Hz) than by no stimulation or low-frequency stimulation (20Hz). The increasing value of muscle force was significantly greater at high-frequency than low-frequency stimulation, suggesting that the clinical application of high-frequency stimulation in acute spinal cord injury should be studied.


Asunto(s)
Terapia por Estimulación Eléctrica/métodos , Atrofia Muscular/prevención & control , Traumatismos de la Médula Espinal/rehabilitación , Enfermedad Aguda , Análisis de Varianza , Animales , Terapia por Estimulación Eléctrica/instrumentación , Diseño de Equipo , Masculino , Atrofia Muscular/etiología , Ratas , Ratas Wistar , Traumatismos de la Médula Espinal/complicaciones
18.
Gan To Kagaku Ryoho ; 28(8): 1129-32, 2001 Aug.
Artículo en Japonés | MEDLINE | ID: mdl-11525030

RESUMEN

We report the a case of 60-year-old male whose final finding was curability C and stage IV scirrhus type gastric cancer because of N3, CY1 and DM (+) treated with a novel oral anticancer drug composed of tegafur (FT), Gimeracil (CDHP) and Oteracil Potassium (Oxo) in a molar ratio of 1:04:1 after operation. This drug was administered orally twice daily after meals at a dose of 80 mg/body/day. One cycle consisted of consecutive administration for 28 days and 14 days rest, and this treatment cycle was repeated twice. Postoperative abdominal CT showed swollen paraaortic lymph nodes regarded as metastasis. However, they were reduced after 1 cycle and remained so. The serum carcinoembryonic antigen (CEA) level had decreased after 1 cycle. The patient's performance status (PS) had also recovered without severe side effects. It was considered that this anticancer drug composed of FT, CDHP and Oxo was effective to scirrhus type gastric cancer and useful as an adjuvant chemotherapy in view of the patient's living quality.


Asunto(s)
Antimetabolitos Antineoplásicos/administración & dosificación , Carcinoma de Células en Anillo de Sello/tratamiento farmacológico , Ácido Oxónico/administración & dosificación , Piridinas/administración & dosificación , Neoplasias Gástricas/tratamiento farmacológico , Tegafur/administración & dosificación , Administración Oral , Carcinoma de Células en Anillo de Sello/cirugía , Esquema de Medicación , Combinación de Medicamentos , Femenino , Humanos , Persona de Mediana Edad , Cuidados Posoperatorios , Neoplasias Gástricas/cirugía
19.
Tohoku J Exp Med ; 193(3): 221-7, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11315769

RESUMEN

A closed-loop control system for standing with functional electrical stimulation (FES) using percutaneous intramuscular electrodes in complete paraplegia is described. The system consisted of ultrafine percutaneous intramuscular electrodes, a 32-channel stimulator and a stretch sensor with active current control to detect knee buckling. The closed-loop control system was applied in a T8 completely paraplegic patient. Compared to the stretch sensor with a wide use flexible goniometer for direct current control during standing, the stretch sensor was superior to the flexible goniometer in both ease of use and response. The average time delay from the start of knee buckling until the sensor turned on was 0.56+/-0.19 seconds (Mean+/-S.D.) in the goniometer and 0.21+/-0.06 seconds in the stretch sensor. The average time delay from the start of knee buckling until the recovery from knee buckling was 1.01+/-0.05 seconds in the goniometer and 0.78+/-0.06 seconds in the stretch sensor. The continuous standing ability of the patient increased from 12 minutes with open-loop stimulation to 30 minutes with the closed-loop control. No complications such as falling occurred during clinical use. This system prevented falling due to knee buckling during standing and prolonged upright activities in complete paraplegics.


Asunto(s)
Terapia por Estimulación Eléctrica/instrumentación , Músculo Esquelético/fisiología , Paraplejía/rehabilitación , Postura/fisiología , Adulto , Electrodos Implantados , Humanos , Pierna/fisiología , Masculino
20.
Am J Chin Med ; 29(1): 173-80, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11321476

RESUMEN

We isolated the phenolic compounds epicatechin, catechin, procyanidin B-1, procyanidin B-2, hyperin and caffeic acid from the hooks and stems of Uncaria sinensis (HSUS), and studied their protective effects against glutamate-induced neuronal death in cultured rat cerebellar granule cells. Cell viability evaluated by MTT assay was significantly increased by application of epicatechin (100-300 microM), catechin (300 microM), procyanidin B-1 (30-300 microM) and procyanidin B-2 (100-300 microM) compared with exposure to glutamate only. 45Ca2+ influx into cells induced by glutamate was also significantly inhibited by administration ofepicatechin (300 microM), catechin (300 microM), procyanidin B-1 (100-300 microM) and procyanidin B-2 (100-300 microM). These results suggest that epicatechin, catechin, procyanidin B-1 and procyanidin B-2 are the active components of HSUS that protect against glutamate-induced neuronal death in cultured cerebellar granule cells by inhibition of Ca2+ influx.


Asunto(s)
Biflavonoides , Ácidos Cafeicos/farmacología , Catequina/farmacología , Ácido Glutámico/efectos adversos , Neuronas/efectos de los fármacos , Plantas Medicinales/química , Proantocianidinas , Quercetina/farmacología , Rubiaceae/química , Animales , Ácidos Cafeicos/química , Ácidos Cafeicos/aislamiento & purificación , Calcio/metabolismo , Catequina/química , Catequina/aislamiento & purificación , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Cerebelo/citología , Relación Dosis-Respuesta a Droga , Ácido Glutámico/farmacología , Estructura Molecular , Neuronas/citología , Neuronas/metabolismo , Fenoles/química , Fenoles/aislamiento & purificación , Fenoles/farmacología , Extractos Vegetales , Tallos de la Planta , Quercetina/análogos & derivados , Quercetina/química , Quercetina/aislamiento & purificación , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA